Neoimmunetech Inc DRC (950220)

Currency in KRW
2,335
-255(-9.85%)
Closed·
950220 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,3302,550
52 wk Range
3673,705
Key Statistics
Bid/Ask
2,335.00 / 2,345.00
Prev. Close
2,590
Open
2,540
Day's Range
2,330-2,550
52 wk Range
367-3,705
Volume
780.65K
Average Volume (3m)
962.97K
1-Year Change
138.5087%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950220 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
12-08-2026
EPS / Forecast
-11.80 / --
Revenue / Forecast
1.17B / --
EPS Revisions
Last 90 days

950220 Income Statement

Compare 950220 to Peers and Sector

Metrics to compare
950220
Peers
Sector
Relationship
P/E Ratio
−9.6x−4.2x−0.4x
PEG Ratio
−0.14−0.100.00
Price/Book
4.2x1.6x2.6x
Price / LTM Sales
133.1x11.8x3.1x
Upside (Analyst Target)
-262.5%49.0%
Fair Value Upside
Unlock1.7%7.0%Unlock

NeoImmuneTech, Inc., a clinical-stage T cell-based biotechnology company, develops and sells immuno-therapeutics in Korea. It is developing NT-I7, an IL-7 class T- cell amplifier to treat acute radiation syndrome; and Heterodimer hybrid Fc platform, an antibody platform technology, as well as NT2020, a T cell activator; NT3020, a T cell engager; NT4010, an advanced CAR-T; and NT5010, a TME modifier. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
6.41M6.49%16.06B
Public Companies & Retail Investors
92.46M93.51%231.60B
Total
98.87M100.00%247.66B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Genexine, Inc.6.49%64,12,1681,60,62,481

FAQ

What Is the Neoimmunetech (950220) Share Price Today?

The Neoimmunetech share price today is 2,335.

What is the current Neoimmunetech (950220) share price and day range?

As of 02-09-2026, the Neoimmunetech share price is 2,335, with a previous close of 2,590. The share price has ranged from 2,330 to 2,550 today, while the 52-week range spans from 367 to 3,705.

What Is the Neoimmunetech Market Cap?

As of today, Neoimmunetech market cap is 230.86B.

What Is Neoimmunetech's Earnings Per Share (TTM)?

The Neoimmunetech EPS (TTM) is -196.

From a Technical Analysis Perspective, Is 950220 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

What Stock Exchange Does Neoimmunetech Trade On?

Neoimmunetech is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Neoimmunetech?

The stock symbol for Neoimmunetech is "950220."

How Many Times Has Neoimmunetech Stock Split?

Neoimmunetech has split 1 times.

How Many Employees Does Neoimmunetech Have?

Neoimmunetech has 52 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.